Published in Transpl Int on September 28, 2010
Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol (2015) 0.95
The anhepatic phase extended by temporary portocaval shunt does not affect anesthetic sensitivity and postoperative cognitive function: A case-control study. Medicine (Baltimore) (2016) 0.75
Usefulness of artificial jump graft to portal vein thrombosis in deceased donor liver transplantation. Yonsei Med J (2015) 0.75
Does the temporary porto-caval shunt have any beneficial impact in orthotopic liver transplantation? Transpl Int (2011) 0.75
Temporary Intraoperative Porto-Caval Shunts in Piggy-Back Liver Transplantation Reduce Intraoperative Blood Loss and Improve Postoperative Transaminases and Renal Function: A Meta-Analysis. World J Surg (2016) 0.75
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27
Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20
Transplant tourism in China: a tale of two transplants. Am J Bioeth (2010) 6.67
Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology (2013) 5.05
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35
Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85
The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res (2009) 3.18
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology (2004) 2.29
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol (2009) 2.18
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol (2006) 1.98
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl (2012) 1.90
Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics (2009) 1.85
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology (2012) 1.83
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol (2010) 1.66
Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65
Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation. Ann Surg (2012) 1.59
A magnetized jet from a massive protostar. Science (2010) 1.55
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg (2015) 1.53
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study. Liver Transpl (2012) 1.49
Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology (2009) 1.48
Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl (2004) 1.44
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res (2012) 1.44
Identification and management of an errant antiperistaltic Roux limb after total gastrectomy. J Gastrointest Surg (2005) 1.43
[One thousand liver transplants. Hospital Clinic i Provincial de Barcelona (Spain)]. Cir Esp (2005) 1.39
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Laparoendoscopic single-site surgery appendectomy. Surg Endosc (2009) 1.30
Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15
Geographic disparity: the dilemma of lower socioeconomic status, multiple listing, and death on the liver transplant waiting list. Clin Transplant (2014) 1.14
Cutaneous metastasis from hepatocellular carcinoma as the first clinical sign. J Hepatobiliary Pancreat Surg (2007) 1.14
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood (2009) 1.13
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc (2012) 1.09
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest (2012) 1.09
Intravascular epithelioid hemangioendothelioma of the inferior vena cava: case report of an unusual and unpredictable vascular tumor. Cardiovasc Pathol (2008) 1.09
Acute liver failure caused by 'fat burners' and dietary supplements: a case report and literature review. Can J Gastroenterol (2011) 1.08
The variable pathology of kidney disease after liver transplantation. Transplantation (2010) 1.08
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
Brief report: Deficits in health care management skills among adolescent and young adult liver transplant recipients transitioning to adult care settings. J Pediatr Psychol (2009) 1.00
Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol (2010) 1.00
Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology (2006) 0.99
Regional variation and use of exception letters for cadaveric liver allocation in children with chronic liver disease. Am J Transplant (2005) 0.98
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transpl (2013) 0.96
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist (2005) 0.96
Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. Surgery (2010) 0.96
Achalasia in a patient with gastroesophageal varices: problematic treatment decisions. Dig Dis Sci (2006) 0.96
Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation (2006) 0.95
Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach. Ann Surg (2015) 0.95
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One (2012) 0.95
Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant (2010) 0.94
Liver transplantation in children weighing 5 kg or less: analysis of the UNOS database. Pediatr Transplant (2011) 0.94
Suprapubic single-incision laparoscopic appendectomy: a nonvisible-scar surgical option. Surg Endosc (2010) 0.94
Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm. J Infect Dis (2013) 0.94
Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res (2011) 0.94
Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B). Am J Surg Pathol (2012) 0.93
Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93
Transesophageal echocardiography utilization in high-volume liver transplantation centers in the United States. J Cardiothorac Vasc Anesth (2008) 0.92
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial. Target Oncol (2013) 0.91
Totally Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy : A New Minimally Invasive Two-Stage Hepatectomy. Ann Surg Oncol (2015) 0.91
Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis (2011) 0.91
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91
Early and frequent histological recurrence of Crohn's disease in small intestinal allografts. Transplantation (2005) 0.91
Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? Liver Transpl (2005) 0.90
Electric foot shock stress-induced exacerbation of alpha-galactosylceramide-triggered apoptosis in mouse liver. Hepatology (2004) 0.90
Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation (2013) 0.89
Propofol: a new treatment strategy for refractory migraine headache. Pain Med (2002) 0.89
Ectopic pancreatic tissue presenting as submucosal gastric mass. J Laparoendosc Adv Surg Tech A (2002) 0.88
Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review. Pediatr Transplant (2015) 0.88
The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin Transplant (2004) 0.88
Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature. Semin Liver Dis (2005) 0.87
Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis (2007) 0.87
Trefoil factor-3 expression in human colon cancer liver metastasis. Clin Exp Metastasis (2008) 0.87
Resection of hepatocellular carcinoma without cirrhosis. Ann Surg (2012) 0.87
Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg (2003) 0.87
Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87
Roux-en-Y loop varices in children with portal hypertension after liver transplantation: an unusual cause of "obscure" gastrointestinal bleeding. Pediatr Transplant (2010) 0.86